Simulations Plus Inc SLP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SLP is a good fit for your portfolio.
News
-
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
-
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
-
Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date
-
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
-
Simulations Plus and the University of Bath Awarded New FDA Grant
-
Simulations Plus Extends Collaboration with Major Toxicology Research Agency
-
Simulations Plus Launches Corporate Development Initiative
-
Simulations Plus to Participate in Upcoming Healthcare Conferences
Trading Information
- Previous Close Price
- $45.00
- Day Range
- $45.00–46.41
- 52-Week Range
- $32.69–52.69
- Bid/Ask
- $45.87 / $48.38
- Market Cap
- $919.31 Mil
- Volume/Avg
- 110,682 / 112,269
Key Statistics
- Price/Earnings (Normalized)
- 46.86
- Price/Sales
- 14.40
- Dividend Yield (Trailing)
- 0.52%
- Dividend Yield (Forward)
- 0.52%
- Total Yield
- 0.54%
Company Profile
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 197
- Website
- https://www.simulations-plus.com
Comparables
Valuation
|
Metric
|
SLP
|
AVDX
|
SCLX
|
|---|---|---|---|
Price/Earnings (Normalized) | 46.94 | 114.11 | — |
Price/Book Value | 5.19 | 3.74 | — |
Price/Sales | 14.43 | 6.38 | 2.65 |
Price/Cash Flow | 54.82 | 79.32 | — |
Price/Earnings
SLP
AVDX
SCLX
Financial Strength
|
Metric
|
SLP
|
AVDX
|
SCLX
|
|---|---|---|---|
Quick Ratio | 8.37 | 0.30 | 0.15 |
Current Ratio | 8.81 | 1.25 | 0.19 |
Interest Coverage | — | −3.96 | −106.04 |
Quick Ratio
SLP
AVDX
SCLX
Profitability
|
Metric
|
SLP
|
AVDX
|
SCLX
|
|---|---|---|---|
Return on Assets (Normalized) | 8.78% | 0.57% | −106.47% |
Return on Equity (Normalized) | 9.45% | 1.89% | — |
Return on Invested Capital (Normalized) | 6.97% | 0.81% | −1,960.39% |
Return on Assets
SLP
AVDX
SCLX
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Qvhfs | $39.4 Bil | |
VEEV
| Veeva Systems Inc Class A | Vvcjwmggx | Lmw | $32.1 Bil | |
SOLV
| Solventum Corp | — | Gmnnww | $11.0 Bil | |
MTHRF
| M3 Inc | — | Ldscbh | $8.3 Bil | |
MTHRY
| M3 Inc ADR | — | Xzbpfcm | $8.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Qcvqnk | $7.2 Bil | |
HQY
| HealthEquity Inc | — | Fmgsn | $6.9 Bil | |
RCM
| R1 RCM Inc | — | Cpd | $5.0 Bil | |
DOCS
| Doximity Inc Class A | — | Ntgbtgd | $4.6 Bil | |
EVH
| Evolent Health Inc Class A | — | Nny | $3.4 Bil |